Rise

Welcome and Opening Remarks

State of the Industry: Navigating the Evolving Medicare Part D Regulatory Landscape

• Stay ahead of CMS priorities with a clear understanding of the latest policy shifts—including updates to Medication Therapy Management (MTM) requirements, pharmacy access standards, and marketing regulations 
• Explore key takeaways from the CMS Final Rule and Call Letter, and what they mean for plan compliance and operations in 2025 and beyond 
• Gain actionable insights into the implementation of the Inflation Reduction Act (IRA), including the $2,000 out-of-pocket cap, the OOP smoothing program, and the timeline for drug price negotiations along with their direct implications for plan design and strategy 

Tom Kornfield 
National Expert on MA and Part D Payment Policy 
Founder and CEO 
MAST Health Policy Solutions  

Compliance Pitfalls: Avoiding Common Mistakes and Preparing for Heightened Oversight

• Dive into case examples of top CMS audit findings and get insights into new areas of focus  
• Prepare for increased scrutiny on IRA-related compliance and how CMS may evaluate your communication strategies and systems readiness for beneficiary education and cost transparency  
• Discuss ways to operationalize compliance improvements, including tools and systems for tracking real-time compliance performance and building internal dashboards  

Ana Handshuh 
Principal 
CAT5 Strategies  

Melissa Wong   
Partner 
Holland & Knight LLP 

Case Study to be announced

Bahar Davidoff PharmD, MBA, SAFe  
Vice President, Pharmacy 
SCAN Health Plan   

Tools and Tech

Managing High-Cost Drugs and the Specialty Pipeline

• Explore strategies to manage the rising costs of GLP-1s and gene therapies while maintaining clinical and financial sustainability 
• Improve forecasting accuracy by understanding how new benefit structures and reinsurance thresholds impact plan liability 
• Discuss how to balance affordability and access while supporting adherence and optimizing the member experience 

Driving Star Ratings Through Part D Performance: What Plans Can Do Now to Improve Outcomes

• Explore strategies to protect your ratings as CMS continues to recalibrate cut points, weighting, and measure specifications, putting even high-performing plans at risk 
• Hear about case examples of plans that are successfully operationalizing pharmacy performance through targeted member engagement, provider partnerships, and real-time analytics 
• Examine which Part D measures move the needle, including adherence, MTM, and CMR completion 

Tina Dueringer, BSN, RN, CCM, PCC  
CEO, Principal Advisor  
Dueringer Advisors, Inc. 

Katharine Iskrant 
Practice Leader  
Healthy People 

Breaking Silos: Cross-Functional Collaboration in Part D Success

Part D success depends on strong coordination between multiple internal departments as IRA requirements take hold. This session features real-world case studies on what works (and what doesn’t) when teams align around shared goals. 

• Learn from real-world examples of how plans tackled formulary changes, OOP cap implementation, and audit readiness together  
• See how data and timelines get derailed or streamlined when teams work in silos vs. in sync 
• Walk away with actionable tactics to improve internal coordination and reduce risk across department 

Iris L. Morant Rodriguez, RPh 
VP Pharmacy Services 
MSO of Puerto Rico  

Roundtables

Participate in a facilitated roundtable discussion and deep dive with peers on timely topics in the industry.  

1. Integrating Risk Adjustment and Part D - Laura Sheriff, RN, MSN, CPC, CRC, Risk Adjustment Industry Expert 
2. TBD 
3. TBD 
4. TBD  

Closing Remarks

Networking Cocktail Reception

Join us for drinks, hors d’oeuvres, and face-to-face networking with peers.